We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI Model Reveals True Biological Age From Five Drops of Blood

By LabMedica International staff writers
Posted on 19 Mar 2025
Print article
Image: A general diagram of the AI-powered biological age model (Photo courtesy of Zi Wang/Osaka University)
Image: A general diagram of the AI-powered biological age model (Photo courtesy of Zi Wang/Osaka University)

Some individuals seem to defy the effects of aging, appearing significantly younger than their peers despite sharing the same age. Aging isn't solely determined by the number of years we have lived; it's also influenced by genetics, lifestyle, and environmental factors. Conventional methods of assessing biological age typically focus on broad biomarkers, like DNA methylation or protein levels. However, these techniques often overlook the complex hormonal systems that regulate the body's internal balance. Now, scientists have developed a novel approach for estimating a person’s biological age, which measures how well the body has aged rather than simply counting the years since birth.

This new method, developed by scientists at Osaka University (Osaka, Japan), uses only five drops of blood to analyze 22 key steroids and their interactions, offering a more precise health assessment. Published in Science Advances, the team’s breakthrough study presents a potential leap forward in personalized health management, enabling earlier identification of age-related health risks and more tailored interventions. Since hormones are essential for maintaining bodily functions, the researchers chose to focus on these as key indicators of aging. To test this hypothesis, the team concentrated on steroid hormones, which are vital in metabolism, immune response, and stress management.

The researchers created a deep neural network (DNN) model that incorporates steroid metabolism pathways, making it the first AI model to consider the interactions between different steroid molecules. Rather than examining absolute steroid levels—which can vary greatly between individuals—the model looks at the ratios of steroids, delivering a more personalized and accurate biological age assessment. Trained on blood samples from hundreds of individuals, the model revealed that biological age differences become more pronounced as people age, an effect the researchers liken to a river widening as it flows downstream.

One of the most surprising findings of the study concerns cortisol, a steroid hormone linked to stress. The researchers discovered that when cortisol levels doubled, biological age increased by about 1.5 times. This suggests that chronic stress could speed up aging at the biochemical level, emphasizing the importance of managing stress to maintain long-term health. The team believes that this AI-driven biological age model could lead to more personalized health monitoring.

Potential future applications for this technology include early disease detection, tailored wellness programs, and lifestyle recommendations to slow the aging process. While the study marks significant progress, the team acknowledges that biological aging is influenced by numerous factors beyond hormones. With continued advancements in AI and biomedical research, the ability to measure—and possibly slow—biological aging is becoming more attainable. For now, the capability to assess an individual’s “aging speed” with a simple blood test could be a revolutionary development in preventive healthcare.

“This is just the beginning,” said Dr. Zi Wang, co-first and corresponding author of this work. “By expanding our dataset and incorporating additional biological markers, we hope to refine the model further and unlock deeper insights into the mechanisms of aging.”

Related Links:
Osaka University

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TRAb Immunoassay
Chorus TRAb
New
Unstirred Waterbath
HumAqua 5

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.